CDC149: A Protein Promoting Cancer and Other Diseases (G91050)

Target Name: CCDC149

NCBI ID: G91050

CCDC149

CDC149: A Protein Promoting Cancer and Other Diseases

CCDC149 is a protein that is expressed in various tissues throughout the body, including the brain, lungs, heart, kidneys, and intestines. It is a member of the carcinoembryonic antigen (CEA) family, which includes proteins that are expressed in a variety of tissues, including cancer cells.

The CCDC149 protein is typically produced in the endoplasmic reticulum (ER), which is the protein synthesis and modification organ of the cell. Once produced, CCDC149 is involved in the development and progression of various diseases, including cancer.

One of the most significant functions of CCDC149 is its role in cancer progression. CCDC149 has been shown to promote the growth and survival of various cancer cell types, including breast, ovarian, and colorectal cancer.

In addition to its role in cancer, CCDC149 has also been shown to be involved in a variety of other processes that are important for human health. For example, it has been shown to play a role in the development and progression of autoimmune diseases, such as rheumatoid arthritis and lupus.

CDC149 is also of interest as a potential drug target. Because CCDC149 is involved in so many different processes in the body, it is a promising target for a variety of therapeutic approaches. For example, researchers have shown that inhibiting CCDC149 can lead to a variety of potential therapeutic effects, including the treatment of cancer, autoimmune diseases, and other conditions.

In addition to its potential therapeutic uses, CCDC149 is also of interest as a biomarker. Because it is expressed in a variety of tissues throughout the body, it can be used as a marker for disease, such as cancer, autoimmune diseases, and other conditions . This makes it an attractive candidate for diagnostic applications, as it can be used to identify and track the progress of these conditions.

Overall, CCDC149 is a protein that has the potential to be a drug target and a biomarker. Further research is needed to fully understand its role in the development and progression of disease, as well as its potential therapeutic and diagnostic applications.

Protein Name: Coiled-coil Domain Containing 149

The "CCDC149 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC149 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets